SV

Street Verdict

Analyst Scorecard

A record of what Chandan Taparia said publicly, with the source. Not advice.

“Bullish on Glenmark; recommends buying at ₹1734 with a target of ₹1855 and a stop loss at ₹1675. The stock gave an inside bar breakout on the daily scale, forming a strong bullish candle, supported by visible buying across Pharma stocks and an upward-headed ADX line confirming strength.”

Chandan Taparia’s track record (trackable calls only): 352 graded calls · 95% CI 32–42%

Glenmark Pharmaceuticals LimitedBullishCalled 09 Oct 2024Graded 24 Oct 2024
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,734, as stated.

Target ₹1,855, stop ₹1,675, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,855 or ₹1,675: there is no fixed window.

The stop ₹1,675 was reached on a close before the target ₹1,855. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1716.8 on 2024-10-21 (stated entry ₹1734, DIP_LIMIT entry, filled); stop ₹1675 breached at close ₹1674.55 on 2024-10-24. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Glenmark Pharmaceuticals Limited since this call

1-year tracking window
Read the original articleSee Chandan Taparia’s full track record